Free Trial
NASDAQ:NYXH

Nyxoah (NYXH) Stock Price, News & Analysis

Nyxoah logo
$8.21 +0.08 (+0.98%)
(As of 11/20/2024 ET)

About Nyxoah Stock (NASDAQ:NYXH)

Key Stats

Today's Range
$8.13
$8.24
50-Day Range
$7.79
$10.00
52-Week Range
$4.00
$20.00
Volume
7,243 shs
Average Volume
26,925 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Buy

Company Overview

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Nyxoah Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
58th Percentile Overall Score

NYXH MarketRank™: 

Nyxoah scored higher than 58% of companies evaluated by MarketBeat, and ranked 390th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nyxoah has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nyxoah has only been the subject of 2 research reports in the past 90 days.

  • Read more about Nyxoah's stock forecast and price target.
  • Earnings Growth

    Earnings for Nyxoah are expected to grow in the coming year, from ($1.91) to ($1.61) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nyxoah is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nyxoah is -4.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nyxoah has a P/B Ratio of 1.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nyxoah's valuation and earnings.
  • Percentage of Shares Shorted

    0.40% of the float of Nyxoah has been sold short.
  • Short Interest Ratio / Days to Cover

    Nyxoah has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nyxoah has recently decreased by 17.42%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Nyxoah does not currently pay a dividend.

  • Dividend Growth

    Nyxoah does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.40% of the float of Nyxoah has been sold short.
  • Short Interest Ratio / Days to Cover

    Nyxoah has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nyxoah has recently decreased by 17.42%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Nyxoah has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Nyxoah this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Nyxoah insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.11% of the stock of Nyxoah is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Nyxoah's insider trading history.
Receive NYXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter.

NYXH Stock News Headlines

Nyxoah’s Voting Rights Shift with ResMed Stake
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
Publication relating to transparency notifications
What is HC Wainwright's Estimate for Nyxoah FY2024 Earnings?
Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript
See More Headlines

NYXH Stock Analysis - Frequently Asked Questions

Nyxoah's stock was trading at $4.64 on January 1st, 2024. Since then, NYXH shares have increased by 76.9% and is now trading at $8.21.
View the best growth stocks for 2024 here
.

Nyxoah (NYXH) raised $83 million in an initial public offering on Friday, July 2nd 2021. The company issued 2,760,000 shares at a price of $30.00 per share.

Top institutional shareholders of Nyxoah include Kovack Advisors Inc..

Shares of NYXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nyxoah investors own include PayPal (PYPL), Confluent (CFLT), Datadog (DDOG), Baidu (BIDU), Arcadia Biosciences (RKDA), SEA (SE) and ZoomInfo Technologies (ZI).

Company Calendar

Today
11/20/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/04/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NYXH
Employees
146
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.00
High Stock Price Target
$20.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+107.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-46,770,000.00
Net Margins
-1,043.93%
Pretax Margin
-1,036.49%

Debt

Sales & Book Value

Annual Sales
$5.08 million
Book Value
$5.08 per share

Miscellaneous

Free Float
N/A
Market Cap
$204.76 million
Optionable
Not Optionable
Beta
1.45
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:NYXH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners